|
Communicating Awareness of (NSAIDs) Risk Effectively (CARE) - Part II
Certified for 1 AMA PRA Category 1 Credit™
Presented by the University of Alabama School of Medicine
Division of Continuing Medical Education
| Release Date: November 21, 2008 |
Expiration Date: November 21, 2011 |
CME Information
Target Audience:
Primary care physicians
Objectives:
Upon completion of this CME activity, participants should be able to:
- Recognize the capacity of NSAIDs to raise blood pressure.
- Describe the prevalence of use of OTC NSAIDs among patients who take a prescription NSAID.
- Describe the role of a medical interpreter in the patient-provider encounter when attempting to learn important information that may be crucial to NSAID prescribing decisions.
- Describe two apects of patient-centered care that can be useful in patient-provider communication regarding the use of NSAIDs.
- Describe two methods of effective medical interviewing that can be used to elicit important patient information (e.g., Kleinman's questions, the LEARN model, or the BATHE model).
- List two questions that can be used to elicit information about patient use of OTC NSAIDs.
Source:
Author:
Monica Crawford, MD
Assistant Professor of Medicine
Department of Immunology/Rheumatology
University of Alabama School of Medicine, UAB
Birmingham, Alabama
Co-Editors:
Jeroan J. Allison, MD, MS
Katie Crenshaw, JD, MSEd
Carlos Estrada, MD, MS
Trudi Horton, PhD
Michael Schoen, PhD
University of Alabama School of Medicine, Division of CME
Disclosure:
Dr. Crawford has disclosed an honorarium from Pfizer. Ms. Crenshaw, Dr. Horton, and Dr. Schoen have disclosed receipt of grant funding from Pfizer. The UAB Division of CME has implemented its mechanism to resolve this potential conflict of interest by validating the content contained herein. Drs. Allison and Estrada have no commercial affiliations to disclose.
This educational initiative is supported through an unrestricted educational grant from Pfizer, Inc.
Because of the nature of preliminary studies, some products mentioned are unlabeled and investigational. Dosages, indications, and methods of use of drugs mentioned in this publication may reflect the experience of the authors, clinical literature, or other resources. Therefore, please see the full prescribing information before using any licensed product mentioned.
CME Participation:
To participate in this online course for CME credit, please review the objectives before beginning the program. Complete the course and the self-assessment test before November 21, 2011 to receive CME credit. Your certificate will then be available online. This process should take approximately 1 hour.
Accreditation:
The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Alabama School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The boards of nursing in many states, including Alabama, recognize Category 1 continuing medical education courses as acceptable activities for the renewal of license to practice nursing.
Disclaimer:
Dosages, indications, and methods of use of any drug referred to in this publication may reflect the clinical experience of the authors, clinical literature, or other clinical resources. Therefore, please see the full prescribing information before using any product mentioned. UAB is an equal opportunity/affirmative action institution.
Course Introduction:
Non-steroidal anti-inflammatory drugs (NSAIDs) are some of the most commonly prescribed medications, but they frequently lead to adverse events. In addition, racial disparities exist in NSAIDs risk awareness, patient-doctor risk communication, and NSAIDs risk behavior. Provision of culturally competent care is one effective means of closing such health disparities and of delivering high-quality care to all patients.
The Division of Continuing Medical Education at UAB has developed a special series of three online courses focusing on effective strategies for discussing the risks and benefits of NSAIDs with patients from diverse backgrounds. These online courses were designed for primary care physicians and other healthcare professionals like you who aspire to excellence in all aspects of practice. Each online course is founded in scientific evidence and illustrates practical techniques you can apply immediately to your work.
Case 1:
The patient is a 57 year-old Mexican man with hypertension, obesity, and bilateral knee osteoarthritis. He does not speak English and brings his 16-year-old daughter to his doctor visits to interpret for him.
BP was modestly elevated at 138/92 at his last visit. His daughter brought in a daily log of home blood pressure recordings which reflected persistent hypertension. His labs were normal, and the physician increased the dose of his antihypertensive medication.
At his visit today, the patient’s BP remains elevated in the same range. The physician asks if the patient has increased his medication as previously recommended, and he responds, “Yes.” He reports no significant dietary changes or decrease in activity level. Upon reviewing his medications, the physician notes that he had recently prescribed an NSAID for the patient’s worsening knee pain when it was no longer responding to acetaminophen.
|